Download a PDF of the full speaker biographies
- Jack M. Anthony, Founder, BioMentorz
- John C. Balzano, JD, Special Counsel, Covington & Burling LLP
- Pey Ni Chan, Managing Director, CMIC Asia-Pacific, Pte. Ltd.
- Helen Chen, Head, China Life Sciences, L.E.K. Consulting
- Do-Hyun Cho, PhD, President & CEO, W Medical Strategies
- Peter B. Corr, Co-Founder and Managing General Partner, Auven Therapeutics
- Robert DeBenedetto, President & CEO, SFJ Pharmaceuticals, Inc.
- Yuan-Hua Ding, PhD, Executive Director, Head of External R&D Innovation – Asia/Pacific, Pfizer Worldwide Research & Development
- Iain D. Dukes, MA, DPhil, Senior Vice President, Business Development & Licensing, Merck Research Laboratories
- Jamie Egan, Senior Vice President, Corporate Development, Anges-MG, Inc.
- Jay N. Fastow, JD, Partner, Ballard Spahr
- David P. Flores, Co-Founder, President & CEO, BioCentury Publications Inc.
- James Foley, Managing Director, Aqua Partners
- Chris Francis, PhD, Vice President, Business Development, WAVE Life Sciences
- Les Funtleyder, Director of Strategic Investments, OPKO Health
- John M. Gill, Co-Founder and former President & CEO (Former) of Tetralogic Pharmaceuticals
- Glen Giovannetti, Global Biotechnology Leader, EY, LLP
- Martyn D. Greenacre, MBA, Former Chairman, BMP Sunstone
- Kimberly Ha, Senior Director, FTI Consulting
- Ed Haug, Partner, Frommer Lawrence & Haug LLP
- Charles Hsu, PhD, Managing Partner, Crosswave Management
- James Huang, Managing Partner, Kleiner Perkins Caufield & Byers China
- Dr. Judy Jarecki-Black, JD, Global Head, Intellectual Property, Merial Limited
- Tae-Wan Kim, PhD, Associate Professor, Columbia University Medical Center
- Chizuko Koseki, Founder & Director, transB Ltd.
- Kiyoshi Kurokawa, Professor, National Graduate Institute for Policy Studies & Former Science Advisor, National Diet, Japan
- Wei Li, PhD, Executive Partner-China, Fidelity Biosciences
- Anjiang (Vincent) Liu, Managing Director, International Investment & Chief Representative, NY Office, FosunPharma Group
- Martina Molsbergen, Chief Executive Officer, C14 Consulting Group
- Keiko Oishi, Senior Managing Director, CMIC Co., Ltd.
- Tomomi Okamoto, Sofia Hill Venture Partners
- Grace L. Pan, Partner, Orrick, Herrington & Sutcliffe LLP
- Andrew L. Pecora, MD, Chairman, TetraLogic Pharmaceuticals Corporation and Chief Visionary Officer, Neostem, Inc.
- Jurij Petrin, MD, President and CEO, Pharmaceutical Regulatory Services, Inc.
- Nathan (Nick) B. Pliam, MD, PhD, Scientist-in-Residence, Bay City Capital LLC
- Terence G. Porter, PhD, Vice President, Search & Evaluation, Global Business Development, Takeda Pharmaceuticals International, Inc.
- Byung-Geon Rhee, PhD, President & CEO, Green Cross Holdings
- Alan Seem, Partner, Shearman & Sterling LLP
- Richard L. Sherman, JD, Senior Vice President, Strategic Transactions, & General Counsel, Tetralogic Pharmaceuticals
- Scott A. Siegel, PhD, Founder, Milestone Life Sciences, LLC
- Anthony Y. Sun, MD, Partner, Aisling Capital
- Goro Takeda, Venture Partner, Sofinnova Ventures
- Mark Tang, PhD, MBA, Founder and Chairman, GCA Therapeutics, Ltd.
- Theodore Torphy, PhD, Senior Vice President, Research & Development, BioMotiv
- Joseph Vacca, PhD, Senior Vice President, Early Success Sharing Partnerships, WuXi AppTec
- Alex Waldron, Vice President Global Commercial Operations, EPIRUS Biopharmaceuticals, Inc.
- Wenyong Wang, PhD, Managing Director, Merchant & Investment Banking, Burrill Securities
- Harold R. Werner, Co-Founder, HealthCare Ventures
- Gunther Winkler, PhD, Founder & CEO, Biometheus LLC
- W. Vincent Xiang, PhD. MBA, Managing Director, Vice President, International Investments and Business Development, Humanwell Healthcare Group
- Alan Yan, Co-Founder, President & CEO, Beijing SynerCare Pharma Tech Co., Ltd.
- Debra Yu, MD, Managing Director, Labrador Advisors
- Peony Yu, MD, Vice President, Clinical Development, FibroGen, Inc.
- Wei Zhang, PhD, Head, Corporate Development, Good Start Genetics Inc.